Article
Ketoconazole 2% cream alters the skin fungal microbiome in seborrhoeic dermatitis: a cohort study
29 Jan 2022
Abstract excerpt
BACKGROUND: Seborrhoeic dermatitis (SD) is a common chronic inflammatory dermatosis. Current theories on the pathogenesis of SD highlight the role of microbes on the skin surface. Ketoconazole is commonly used for the treatment of SD; however, there are limited data focusing on the effects of ketoconazole in shaping the skin microbiome in patients with SD. AIM: In this prospective cohort study, we used a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
